US Global Health Research Funding Falls Short of Innovation Rhetoric

Thursday, March 27, 2014

On Thursday, the Global Health Technology Council will make its case on Capitol Hill in a Senate briefing aimed at convincing lawmakers that American global leadership demands funding for U.S. global health technologies and products — including low-cost vaccines, drugs, diagnostics and devices that can combat diseases endemic to the developing world.

The combined effects of across-the-board sequestration spending cuts and the U.S. government shutdown last year — as well a presidential budget request that cuts global health funding 4.6 percent for fiscal year 2015 — have some advocates worried U.S. leadership on global health research and development could be waning.

Source: Devex (link opens in a new window)

Health Care
healthcare technology, vaccines